ProteinLogic Company Profile: Funding, Investors & Partnerships

ProteinLogic

Developer of a novel diagnostic technology platform designed to treat infectious, autoimmune, and inflammatory diseases. The company's technology is based on the detection of non-obvious diagnostic patterns in the soluble immune proteins in the blood and other body fluids through machine learning and these patterns form unique signatures of disease presence, stage, and potential response to treatment, enabling healthcare professionals to avail diagnostic tests for personalized medicine.Developer of a novel diagnostic technology platform designed to treat infectious, autoimmune, and in Show More

Alpha Score

43.9

Total Funding$ 10.92 M